CTRI/2022/03/040851
Completed
未知
ASSESSMENT OF EARLY TREATMENT RESPONSE AND DOSIMETRIC EVALUATION IN LOCALLY ADVANCED CERVICAL CANCER TREATED WITH 3D CONFORMAL RADIATION THERAPY ALONG WITH CONCURRENT CISPLATIN AND IMAGE GUIDED HIGH DOSE RATE BRACHYTHERAPY
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- GOODHealth Condition 2: C539- Malignant neoplasm of cervix uteri, unspecified
- Sponsor
- AIIMS
- Enrollment
- 21
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Biopsy proven carcinoma of cervix 2\. Age : between 18\-65 yrs 3\. FIGO Stage IIB â?? IIIB 4\. Karnofsky performance scale score 70 or above 5\. Normal kidney, liver and bone marrow function 6\. Patient who have given informed consent
Exclusion Criteria
- •1\. Early stage cancer FIGO stage IA â??IIA 2\. Metastatic patients 3\. Lack of Histo\-pathological proof of malignancy 4\. Doubtful follow\-up and /or non\-compliance 5\. Uncontrolled co\-morbid conditions e.g. Hypertension, Diabetes Mellitus, Chronic Obstructive pulmonary disease (COPD), coronary artery disease (CAD), Severe Mental or Physical Disorder 6\. Pregnancy 7\. Deranged renal, liver function test 8\. Patient refusing to give written informed consent 9\. H/O\- of previous irradiation 10\. H/O\-of allergy 11\. Collagen vascular disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Early evaluation of therapy response (targeted therapy and immunotherapy) in patients with metastasized malignant melanoma by multiparametric PET/MR imaging.C43.9Malignant melanoma of skin, unspecifiedDRKS00013925niversitätsklinikum Tübingen, Radiologische Klinik, Diagnostische & Interventionelle Radiologie62
Recruiting
Not Applicable
ERASE_Evaluation of early treatment response of soft tissue sarcomas under neoadjuvant hyperthermia and chemotherapy using functional MRI as well as FDG PET-CTC41.9C41Bone and articular cartilage, unspecifiedMalignant neoplasm of bone and articular cartilage of other and unspecified sitesDRKS00016070Klinikum der Universität München, Campus Großhadern35
Active, not recruiting
Not Applicable
Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes - DEFEND 2Type 1 Diabetes MellitusMedDRA version: 12.1Level: LLTClassification code 10012608Term: Diabetes mellitus insulin-dependentEUCTR2010-018775-17-ITTolerx, Inc.396
Withdrawn
Phase 3
Durable-Response Therapy Evaluation For Early -or New-Onset Type 1 Diabetes.Type-1 Diabetes10003816NL-OMON34462Tolerx Inc.25
Completed
Not Applicable
Early treatment effect and prognosis measurement of bone metastasis in prostate cancer patients by using whole-body diffusion-weighted imaging.prostate cancerJPRN-UMIN000035857Keio University60